Mitsubishi Chemical Holdings Corporation (MCHC) has announced the transfer of Life Science Institute Inc’s affiliate, Qualicaps to Mitsubishi Chemical Corporation (MCC), with effect from 1 July.
“Through this transfer, MCC will enable Qualicaps to provide higher value-added solutions to the global capsule market by not only strengthening manufacturing technology leveraging mutual resources and accelerating chemical materials development, but also bolstering sales through collaboration among MCC business domains,” the company said in a press release.
Qualicaps is based in Japan and focuses on the production, manufacture and distribution of capsules for pharmaceutical, health and nutrition products, as well as pharmaceutical processing equipment (PPE).
In 2013, Mitsubishi Chemical Holdings bought stake in Qualicaps and made its consolidated subsidiary.
Life Science Institute Inc was established in April 2014. As a group company of Life Science Institute, Qualicaps has contributed to the growth of MCHC Group’s health care domain by offering high-performance hard capsules, as well as the development of and provision of technical services for PPE.